IRD

Opus Genetics, Inc. - Common Stock (IRD)

About Opus Genetics, Inc. - Common Stock (IRD)

Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Durham, NC.

Details

Daily high

$6.22

Daily low

$5.80

Price at open

$6.02

52 Week High

$7.07

52 Week Low

$1.35

Market cap

502.5M

Dividend yield

Volume

38,350

Avg. volume

4.7M

P/E ratio

-4.39

Opus Genetics, Inc. - Common Stock News